Cargando…

79. Long-term Health Outcomes of Individuals who are Infected with SARS-CoV-2 and Develop COVID-19

BACKGROUND: Persistence of symptoms after the acute phase of COVID-19, often referred to as long COVID, is common and debilitating. Data on the burden and direct medical costs of long COVID is still limited. METHODS: A retrospective cohort study using data from a 2.6-million-member state-mandated he...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tene, Lilac, Bergroth, Tobias, Eisenberg, Anna, Chodick, Gabriel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752216/ http://dx.doi.org/10.1093/ofid/ofac492.004

Ejemplares similares

Real-World Utilization of Molnupiravir during the COVID-19 Omicron Surge in Israel
por: Weil, Clara, et al.
Publicado: (2023)

Assessment of Effectiveness of 1 Dose of BNT162b2 Vaccine for SARS-CoV-2 Infection 13 to 24 Days After Immunization
por: Chodick, Gabriel, et al.
Publicado: (2021)

Iron deficiency and the effectiveness of the BNT162b2 vaccine for SARS-CoV-2 infection: A retrospective, longitudinal analysis of real-world data
por: Tene, Lilac, et al.
Publicado: (2023)

434. Characteristics and long-term outcomes of SARS-CoV-2 associated myocarditis cases in the Military Health System
por: Pollett, Simon, et al.
Publicado: (2023)

Mental Health Consequences of SARS-CoV-2 Pandemic on Long-Term Care Facility Social Care Provider in Poland
por: Szcześniak, Dorota, et al.
Publicado: (2021)

2318. Utility of Routine Asymptomatic Post-Admission SARS-CoV-2 Screening in a Rehabilitation Facility
por: Williams, Victoria R, et al.
Publicado: (2023)

Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals
por: Lingel, Holger, et al.
Publicado: (2021)

COVID-19 Breakthrough Infections in Vaccinated Patients With CLL in Israel
por: Yekutiel, Naama, et al.
Publicado: (2023)

454. How Useful is SARS-CoV-2 Antigen Detection in Individuals Admitted to the Hospital With no Respiratory Symptoms?
por: Prince, Monique A, et al.
Publicado: (2023)

Long-Term Elevated Inflammatory Protein Levels in Asymptomatic SARS-CoV-2 Infected Individuals
por: Tserel, Liina, et al.
Publicado: (2021)

Age Differences in Becoming COVID Long-Haulers and in Post-Acute Sequelae of SARS-CoV-2
por: Wu, Qiao, et al.
Publicado: (2021)

Neuropsychiatric manifestations of SARS-CoV-2 infection
por: Nogueira, V., et al.
Publicado: (2021)

Long-Term Health Consequences of SARS-CoV-2: Assumptions Based on SARS-CoV-1 and MERS-CoV Infections
por: Khaswal, Ashutosh, et al.
Publicado: (2022)

Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine
por: Mizrahi, Barak, et al.
Publicado: (2021)

Waning of SARS-CoV-2 booster viral-load reduction effectiveness
por: Levine-Tiefenbrun, Matan, et al.
Publicado: (2022)

484. Clinical Description of SARS-CoV-2 Infection in Patients with Primary Antibody Deficiency Who Received Tixagevimab/Cilgavimab Prophylaxis
por: Lim, Sung Min, et al.
Publicado: (2023)

SARS-CoV-2 and the brain to be studied long-term
por: Lemprière, Sarah
Publicado: (2020)

464. Whole Genome Sequencing and Mutation Analysis of SARS-CoV-2 in the Immunocompromised Patients with Persistent SARS-CoV-2 Shedding
por: Chang, Eui Jin, et al.
Publicado: (2023)

452. Ongoing Surveillance of SARS-CoV-2 for In Silico Analysis to Monitor the Performance of SARS-CoV-2 Assays in BIOFIRE® Panels
por: Horrocks, Eleanor K, et al.
Publicado: (2023)

1879. Detection of COVID-19 Outbreaks in Long-Term Care Homes Using Built Environment Testing for SARS-CoV-2: A Multicentre Prospective Study
por: Fralick, Michael, et al.
Publicado: (2022)

482. Long-Term Outcomes of Coronavirus disease 2019 and Risk Factors for Prolonged SARS-CoV-2 Infection in Lymphoma Patients: Multicenter, Retrospective Cohort Study
por: Lee, Jung Ah, et al.
Publicado: (2023)

The association of neonatal SARS-CoV-2 anti-spike protein receptor-binding domain antibodies at delivery with infant SARS-CoV-2 infection under the age of 6 months: a prospective cohort study
por: Oz-Alcalay, Lital, et al.
Publicado: (2023)

Long-Term Headache and Cognitive Complaints Among Health Care Workers Who Acquired SARS-CoV-2
por: Marques, Ana João, et al.
Publicado: (2023)

79th Meeting of the Ulster Society of Internal Medicine
Publicado: (2008)

Long-term memory CD8(+) T cells specific for SARS-CoV-2 in individuals who received the BNT162b2 mRNA vaccine
por: Kuse, Nozomi, et al.
Publicado: (2022)

376. Sensitivity and Specificity of the WHO Probable SARS-CoV-2 Case Definition Among Symptomatic Healthcare Personnel
por: Nguyen, Han, et al.
Publicado: (2021)

477. Characteristics and Long-Term Outcomes of Cardiac Complications of SARS-CoV-2 in Youth: Results from the EPICC YES C3 Prospective Longitudinal Cohort Module
por: Jones, Milissa U, et al.
Publicado: (2023)

1356. "Correlates of protection against SARS-CoV-2 post-vaccine infections in the Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) Study"
por: Goguet, Emilie, et al.
Publicado: (2023)

1336. Presence of Antibodies to non-SARS-CoV-2 Associates With Generation of Neutralizing Antibodies to SARS-CoV-2 Following mRNA Vaccination
por: Al Hammoud, Roukaya, et al.
Publicado: (2023)

Gene signatures of SARS-CoV/SARS-CoV-2-infected ferret lungs in short- and long-term models
por: Liu, Hsin-Liang, et al.
Publicado: (2020)

Long term persistence of coronavirus SARS-CoV-2 infection
por: Pinho, João Renato Rebello, et al.
Publicado: (2021)

Long-Term Antibody Response to SARS-CoV-2 in Children
por: Dunay, Gabor A., et al.
Publicado: (2022)

Long-term neurological sequelae of SARS-CoV-2 infection
Publicado: (2022)

Long-term Outcome of Chilblains Associated with SARS-CoV-2
por: POIZEAU, Florence, et al.
Publicado: (2021)

Long‐term disruption of cytokine signalling networks is evident in patients who required hospitalization for SARS‐CoV‐2 infection
por: Ahearn‐Ford, Sinead, et al.
Publicado: (2021)

Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS-CoV-2: Insights from a large healthcare database analysis
por: Gendelman, Omer, et al.
Publicado: (2020)

Cellular Immunity—The Key to Long-Term Protection in Individuals Recovered from SARS-CoV-2 and after Vaccination
por: Primorac, Dragan, et al.
Publicado: (2022)

1064. Intra-Host SARS-CoV-2 Evolution Dynamics
por: Haddad, Kim El, et al.
Publicado: (2022)

2284. SARS-CoV-2 Transmission in Utah Nursing Homes
por: Bohman, Julia, et al.
Publicado: (2023)

2299. Genomic Epidemiology of SARS-CoV-2 in Metropolitan Detroit
por: Kaur, Jagjeet, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_m9uam60fjba68prtchussaj0av